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RCCAbstract Objectives: The aim of this study was to assess the role of multi-detector computed
tomography (MDCT) in diagnosis and preoperative staging of solid renal masses.
Patients and methods: During two years duration we prospectively evaluated 56 patients with solid
renal lesions previously detected by US. All patients underwent multiphasic CT scanning for the
kidneys and urinary tract following a preset scanning protocol that included unenhanced, cortico-
medullary phase (CMP), nephrograhic phase (NP) and excretory phase (EP) scanning. The images
obtained in the excretory delayed phase were reconstructed in different planes to obtain 2D and 3D
reformatted images providing volume rendering VR and maximum intensity projection (MIP) CTU
images. Curved reformatting was sometimes used for the ureter. The numbers of lesions detected in
all three phases were determined. Results of CT scan were compared with histopathology or con-
stellation of clinical and imaging patient data.
Results: A total of 61 masses were detected in 56 cases, 51 cases had unilateral masses (91%), 5
cases had bilateral masses (9%). The different pathologies encountered in the study were RCC
39 masses (64%), Wilm’s tumor 3 masses (4.9%), transitional cell carcinoma 3 masses (4.9%), angi-
omyolipoma 7 masses (11.5%), lymphoma 6 masses (9.8%), metastasis one mass (1.6%), angiomy-
olipoma associated with RCC two masses (3.3%). Lymph nodal metastasis, renal vein, IVC
thrombosis and distant metastatic spread in different pathologies were assessed.
The attenuation HU values calculated in the early CMP for all cases of RCC had a mean value of
80.5 HU (STD 45.7) while the mean values in NP and EP were 70.6 HU (STD 25.4) and 51.3 HU
(STD 19.2) respectively.
A pattern of enhancement was detected in all cases of RCC in the form of rapid wash out of con-
trast and decrease of attenuation (HU) by time throughout different phases.
Signiﬁcant difference between HU in CMP and EP in cases of RCC (P value = 0.0002) and differ-
ence between HU in NP and EP in cases of RCC (P value < 0.00001) were found.ed.
216 M.H. Wahba et al.Conclusion: Multiphase multislice computed tomography combined with CT angiography and CT
urography have a major role in solid renal neoplastic masses’ diagnosis, characterization and dif-
ferentiating benign and malignant tumors.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Improvement in imaging modalities continues to have a large
impact on the diagnosis and treatment of solid renal masses.
As many as 30–40% of renal tumors are discovered inciden-
tally during evaluation of unrelated or unspeciﬁc symptoms,
and many lesions can be appropriately treated with local exci-
sion and maximal preservations of the surrounding unaffected
parenchyma (1).
The advent of multi detector CT scan has enabled us to
delineate the mass, detect and map the extent of venous
spread, lymph nodal enlargement and diagnose local or distant
spread. (2) Accordingly, differentiation between benign and
malignant masses and accurate staging of malignant ones
was obtained. Treatment regimen is then planned whether
medical or surgical solutions (6).
The aim of this study was to assess the role of multi-
detector computed tomography (MDCT) in diagnosis and
preoperative staging of solid renal masses.
2. Patients and methods
2.1. Patients
During two years duration ﬁfty-six patients were prospectively
included in this study. They were referred to the Radiology
department in Cairo University Hospitals for further assess-
ment of renal masses previously detected by US using mutli-
phase MDCT of the urinary system. These patients were 33
males and 23 females with their ages ranging between 3 and
75 years (mean 47.4 years, STD 17.43).
They were subjected to full clinical history and routine
laboratory investigations as well.
2.2. Methods
All patients underwent multiphasic CT scanning following a
preset scanning protocol that included unenhanced, corticome-
dullary phase (CMP), nephrograhic phase (NP) and excretory
phase (EP) scanning.
The examination was performed using sixty-four section
MDCT scanner (Aquillion, Toshiba Medical Systems, Japan).
For acquisition of all images, a tube voltage of 140 kVp, a tube
current of 200–300 mA, slice thickness of 1.25 mm, pitch of
1:1.5, speed 7.5 mm per rotation, gantry rotation 0.8 s were
used.
In all patients, initial scanning was done before administra-
tion of contrast medium. The non enhanced phase was done at
5 mm thickness and speed 15 mm per rotation.
Patients then received 2 ml/kg body weight of low osmolar
non-ionic contrast medium (Ultravist 300 mg/ml, Bayer) at the
rate of 3.5–4 ml/s and 150 mmHg. The NP images wereobtained with a delay of 50 s after initiation of contrast med-
ium injection, scanning time about 30 s. The EP delay was
obtained with 350–400 s delay and scanning time 60 s. In the
precontrast scan and EP the area scanned was from the level
of diaphragm to symphysis pubis. However in CMP and NP,
scanning area was from the diaphragm to iliac crest.
2.3. Data analysis and interpretation
All images throughout different phases of the examination
were sent to remote workstation (Vitrea Workstation). The
images obtained in the early arterial phase were reconstructed
in different planes to obtain 2D and 3D reformatted images
providing VR and MIP CTA images.
The images obtained in the excretory delayed phase were
reconstructed in different planes to obtain 2D and 3D refor-
matted images providing VR and MIP CTU images. Curved
reformatting was used for the ureter.
After conﬁrmation of the presence of solid renal mass, cer-
tain information was then fulﬁlled including their locations,
extensions, relation to collecting system, peri-nephric spread,
local inﬁltrations, venous involvement, renal vascular anat-
omy, regional lymph nodes and distant abdominal and lung
bases metastasis.
Staging depends on the previously collected data. TNM
score was used in cases of RCC.
A certain region of interest (ROI) was determined within
the mass in condition not to include calciﬁcations or areas of
cystic degenerations which may result into false high or low
attenuation values. We kept the sizes and locations of the
regions of interest the same for each patient’s images from
the three scanning phases. The attenuation (HU) in each
ROI was calculated automatically using DICOM image
viewer. All values were collected and tabulated aiming to
obtain certain pattern of enhancement for each group of
pathology. The MSCT ﬁndings were correlated with the results
of histopathological ﬁndings after surgery and follow up.3. Results
A total of 61 solid renal masses were detected in 56 cases, 51
cases had unilateral masses (91%), 5 cases had bilateral masses
(9%). These 5 cases with bilateral lesions include one case of
bilateral angiomyolipoma, one case of bilateral renal cell car-
cinoma (Fig. 1) and 3 cases of bilateral lymphoma. The one
case of bilateral angiomyolipoma was diagnosed as tuberous
sclerosis after further investigations of other systems by
different imaging modalities.
Out of 61 masses, 54 masses (88.5%) were malignant and 7
masses (11.5%) were benign. The different pathologies
encountered in the study were renal cell carcinoma (RCC) 39
masses (64%), Wilm’s tumor 3 masses (4.9%) (Fig. 2),
Fig. 1 30 year old patient presented with abdominal pain and hematuria. MDCT: Left kidney: Large well deﬁned lower zonal soft tissue
mass (arrow heads) showing heterogeneous texture and measuring >7 cm in diameter. It shows intense enhancement in the CMP and
rapid wash out in the following NP (HU is 124.6 in CMP, 81.3 in NP and 61.6 in EP). The mass extends beyond the renal fascia with
multiple linear streaky densities and minimal amount of ﬂuid. Patent left renal vein and IVC. Another large predominantly cystic mass is
also seen at the upper pole. Right kidney: Small rounded well deﬁned cortical lower pole soft tissue mass lesion (arrows) measuring <4 cm
in diameter with no evidence of local inﬁltration. Multiple variable sized enlarged abdominal lymph nodes are seen involving the para-
aortic, celiac and superior mesenteric groups. CTA: Hypertrophied left main renal artery (curved arrows) and supplying segmental
branches with early venous ﬁlling of the draining veins. CTU: Dilated left pelvicalyceal system with no evidence of invasion. The left ureter
is seen displaced anteriorly and medially. Normal size and conﬁguration of the right pelvicalyceal system. Diagnosis: Bilateral renal cell
carcinoma, left (Sarcomatoid subtype) T4 N2 M1, right (Clear cell subtype).
Multiphasic MDCT in diagnosis and staging of solid neoplastic renal masses 217transitional cell carcinoma 3 masses (4.9%), angiomyolipoma
7 masses (11.5%), lymphoma 6 masses (9.8%), metastasis
one mass (1.6%), angiomyolipoma associated with RCC two
masses (3.3%) as listed in Table 1.
The MSCT were correlated with the results of histopathol-
ogy and follow up. Lymph nodal metastasis, renal vein, IVC
thrombosis and distant metastatic spread in different patholo-
gies were assessed. The CT diagnosis of lymph node metastases
was reliant on nodal enlargement of greater than 1 cm in short-
axis diameter.
Nine out of 39 RCC (23%) masses have shown lymph
nodal metastasis while all Wilm’s and lymphoma masses have
shown nodal metastasis (100%).
Perinephric extension was detected in 16 renal masses.
Eight out of 39 RCC (20.5%), in 2 out of 3 (66.6%) Wilm’s
tumors and in all six cases (100%) of lymphoma.
Four out of 39 RCC masses had distant metastatic spread
(10%) (three cases with lung metastasis and one case with liver
metastasis), two out of 3 Wilm’s masses (66.6%) while all lym-
phoma and metastasis masses (100%) had distant abdominal
metastatic spread as listed in Table 2.Two out of seven cases of angiomyolipoma, demonstrated
appreciable fat on CT images and the diagnosis was done
based on CT ﬁndings (Fig. 3), they showed a stable course in
1 year follow up. While the remaining 5/7 cases (71%) showed
absence of fat density which necessitates further surgical
assessment and pathological diagnosis.
Among 39 masses of RCC, 2 cases had renal vein thrombo-
sis with a percentage of 5%. These two cases showed thrombus
extension to inferior vena cava (IVC).
Thirty-nine masses in 38 cases were subjected to TNM clas-
siﬁcation, 13 cases of RCC (34%) were staged as T1a due to
small size of the mass (<4 cm). Ten cases of RCC (26%)
had masses measuring 4–7 cm in diameters and staged as
T1b. 7 cases of RCC (18.4%) staged as T2 had large masses
(>7 cm in diameters).
Two out of 38 RCC cases (5%) showed extension to the
peri renal fat and staged as T3a while one case (2.6%) staged
as T3c had renal vein thrombosis extending to the IVC above
the diaphragm (Fig. 4).
Local inﬁltration and extension of the neoplastic mass
beyond the renal fascia were detected in 5/38 cases (14%)
Fig. 2 A 14 year old female patient presented with marked
abdominal distension and contour bulge of the abdominal cavity.
MDCT: Large soft tissue mass (arrow heads) occupying most of
the abdominal cavity and crossing midline showing large ill
deﬁned cystic areas (asterisk). CTA: The right main renal artery is
inconspicuous. Multiple arterial collaterals (arrows) are seen
supplying the mass originating from the celiac trunk, superior
and inferior mesenteric, common iliac and epigastric arteries.
CTU: No evidence of contrast excretion by the right kidney.
Diagnosis: Wilm’s tumor, Stage III.
Table 1 Different pathologies encountered in the study.









218 M.H. Wahba et al.diagnosed as T4. One among these cases also had renal vein
and IVC thrombosis extending to a level below the diaphragm.
Regional lymph nodal metastasis limited to one group of
nodes was detected in 5 cases (10%) (N1) and in more than
one group of lymph nodes in 4 cases (10%) (N2) Table 3,
distant metastasis was detected in 4 cases (10.5%) with 2 casesshowing liver metastases and 2 cases showing basal lung
metastases.
We measured the HU of TCC and RCC cases in CMP, NP
and EP .The attenuation HU values calculated in the early
CMP for all cases of RCC had a mean value of 80.5 HU
(STD 45.7) while the mean values in NP and EP were
70.6 HU (STD 25.4) and 51.3 HU (STD 19.2) respectively.
A pattern of enhancement was detected in all cases of RCC
in the form of rapid wash out of contrast and decrease of
attenuation (HU) by time throughout different phases (Fig. 5).
Signiﬁcant difference between HU in CMP and EP in cases
of RCC (P value = 0.0002) and difference between HU in NP
and EP in cases of RCC (P value < 0.00001) were found.
Pathologically proven cases of RCC clear cell subtype
showed intense enhancement in the early CMP (HU 144.7
and 129.7) and rapid wash out of contrast in the following
NP (HU 79.8 and 88.4) respectively. The pathologically proven
case of papillary subtype showed minimal enhancement in the
CMP (HU 55.5) and homogenous faint enhancement in the
NP (HU 83.1) (Fig. 6).
39 RCC masses (regardless of their pathological subtypes)
showed intense enhancement in the CMP (mean 80.5 HU,
STD 45.7), rapid decrease of enhancement in the following
NP (mean 70.6 HU, STD 25.4) denoting rapid wash out of
contrast and ﬁnal decrease of HU in the EP (mean 51.3 HU,
STD 19.2). A signiﬁcant difference was detected between HU
in CMP and EP in cases of RCC (P value = 0.0002) and dif-
ference between HU in NP and EP in cases of RCC (P
value < 0.00001).
TCC (3 cases) showed a faint enhancement in the CMP
(mean 40.6 HU, STD 27.8), further increase of enhancement
in the following NP (mean 59.4 HU, STD 8.7) and ﬁnal
decrease of HU in the EP (mean 37.1 HU, STD 19.8). A signif-
icant difference was detected between HU in NP and EP in
cases of TCC (P value = 0.03).
4. Discussion
Improvement in imaging modalities continues to have a large
impact on the diagnosis and treatment of solid renal masses.
As many as 30–40% of renal tumors are discovered inciden-
tally during evaluation of unrelated or unspeciﬁc symptoms.
(1,18).
Multidetector spiral CT remains the single most effective
imaging modality for the diagnosis and staging of renal cell
carcinoma. In the majority of patients, it is the only imaging
test needed prior to surgical management. Advances in data
acquisition and display, including three-dimensional volume
Table 2 Showing lymph nodal metastasis and perinephric extension and distant metastatic spread detected, the CT diagnosis of
lymph node metastases is reliant on nodal enlargement of greater than 1 cm in short-axis diameter.
Pathology LNs Perinephric extension Distant metastasis
No % No % No %
RCC 9/39 23 8/39 20.5 4/39 10
Wilm’s 3/3 100 2/3 66.6 2/3 66.6
TCC 0/3 0 0/3 0 0/3 0
Lymphoma 6/6 100 6/6 100 6/6 100
Metastasis – – – – 1/1 100
Fig. 3 MDCT: Large right renal lower pole cortical soft tissue mass showing heterogeneous texture, areas of intense enhancement and
areas of fat densities (arrows). CTA: No pathological circulation. Multiple dilated and tortuous vascular channels with early venous ﬁlling
of the hypertrophied draining veins. CTU: No abnormality detected. Diagnosis: Angiomyolipoma.
Multiphasic MDCT in diagnosis and staging of solid neoplastic renal masses 219rendering techniques, provide unparalleled capabilities for the
detection, staging, and management of primary renal cell car-
cinoma (2,8).
Treatment decisions hinge on the extent and stage of the
tumor. Since the only curative treatment for renal cell carci-
noma remains complete surgical excision, the goals of preoper-
ative CT are to delineate the primary tumor, detect and mapthe extent of venous spread, and diagnose local or distant
metastases (12).
Dedicated renal CT performed for the diagnosis and stag-
ing of renal solid neoplasm must include a combination of
image data acquisitions, despite the added radiation exposure
and cost. Better detection and characterization of renal masses,
as well as more accurate staging, are possible when the
Fig. 4 A 57 year old male patient presented with continuous right hypochondrial pain, recurrent attacks of hematuria, and rapid loss of
weight. MDCT: The right kidney is almost totally replaced by a large soft tissue mass, sparing the upper pole with heterogeneous texture,
intense enhancement in the CMP and rapid wash out of contrast in the following NP and become hypodense the EP. The mass extends
beyond the perirenal fascia. Right adrenal deposit (black arrow). Multiple variable sized hepatic deposits (white arrows). Multiple
enlarged abdominal and pelvic lymph nodes. The renal vein and IVC are distended and totally occluded by tumoral thrombus (arrow
heads). The thrombus extends caudally till CIV and cranially crossing above the diaphragm and reaching the right atrium (curved arrows).
Diagnosis RCC T4 N2 M1.
220 M.H. Wahba et al.scanning protocol includes a combination of unenhanced CT
and imaging in the corticomedullary and nephrographic
phases (4,13).
In this study we assessed the role of MSCT for the diagno-
sis and preoperative staging of solid renal lesions. Fifty six
patients with 61 renal masses were prospectively evaluated
using MSCT in different phases. MSCT was useful for charac-
terization of renal lesions, as it failed to diagnose only 5 casesof AML due to absence of characteristic fat density. The non
fat containing angiomyolipoma accounts for 8.9% in our
study with diagnostic accuracy of the MSCT reaching 91%,
consistent with the study of Zhang et al. (17).
In this study we performed CT staging for malignant renal
lesions. We found that most of RCC lesions (33 cases, 54.5%)
were early stage; (8 cases T1a, 24.2% and 10 cases T1b, 3.0%).
This is consistent with the downward migration in the size and
Table 3 TNM staging in 38 RCC cases.
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over the last decade. Despite the generally small sizes of these
lesions, their characterization based on imaging features and
degree of enhancement could be achieved. That is in agreement
with the study of (17) that reported most of the patients had
early-stage tumors at the time of presentation (T1a, 62%;
T1b, 12%; T2, 8%; T3, 13%; and T4,<1%).
The rest of our RCC cases had more advanced stages as 7
cases were staged T2 (21.2%), 2 cases T3a (6%), 1 case T3b
(3%) and 5 cases T4 (15.1%) with a total of 15 cases represent-
ing 45.4% of RCC cases. These results demonstrate that our
patient population had renal cell carcinomas of relative
delayed stages compared to other studies as those of (18).
The evaluation of renal vein thrombosis is crucial for treat-
ment planning; in fact, if tumor thrombus spreads into the
inferior vena cava, the exact extent of the thrombus is essential
for planning the correct surgical approach: an abdominal inci-
sion is performed if the thrombus is infra hepatic, whereas a
thoraco-abdominal incision is needed if the thrombus extends
more cranially (1). Two patients in this study with the diagno-
sis of RCC had renal vein and IVC invasion (6%) staged as
T3c and T4. One case had supra diaphragmatic extension till
the right atrium.
Ng et al. and Sheth et al.(2,12) reported that extension of
renal cell carcinoma into the renal vein alone (stage T3b)
occurs in approximately 23% of patients and does not
adversely affect the prognosis. Spread of the tumor into the
IVC is found in 4–10% of patients (14).
Our result goes with Staehler and Brkovic (14) regarding
IVC thrombosis while percentage of renal vein thrombosis in
our study is lower than Sheth et al. (12) possibly due to smaller
number of patients in our study and majority of cases in early
stages (54.5% of RCC T1a and T1b).
Involvement of the perirenal fat tissue represents a key
point in treatment planning. In fact, the inﬁltration of the per-
irenal fat tissue modiﬁes the surgical approach from conserva-
tive to radical nephrectomy (15).
Under and over staging of perinephric invasion are the
most common staging errors at CT. The most speciﬁc ﬁnding
of stage T3a disease, is the presence of an enhancing nodule in
the perinephric space. (12). Tumor mis-staging after MDCT is
of little clinical importance, however in our study large tumor
size>7 cm (18.4%) is a risk factor for tumor mis-staging and
this is in line with that stated in (3).In our study, out of 54 malignant masses, perinephric
extension was seen in 16 renal masses, eight out of 39 RCC,
2 out of 3 Wilm’s tumors and all 6 cases of lymphoma. Local
inﬁltration and extension of the neoplastic mass beyond the
renal fascia were detected in 5 cases (14%) diagnosed as T4.
One among these cases had also renal vein and IVC thrombo-
sis extending to a level below the diaphragm.
Despite its complexity, the TNM classiﬁcation, which
deﬁnes the anatomic extent of the tumor more precisely, has
gained wide acceptance (10).
Regarding lymph nodal metastasis our study included 29
cases of RCC (72.7%) that had not been associated with
lymph nodal enlargement N0. However Sheth et al. (12) stated
that in more than half of the patients in their study, nodal
enlargement was caused by benign inﬂammatory changes.
Nodal enlargement shown at CT should not disqualify patients
from nephrectomy unless metastatic spread is conﬁrmed with
ﬁne-needle aspiration.
Among all renal cortical tumors detected, approximately
20% are benign lesions and 25% are relatively indolent papil-
lary or chromophobe carcinomas. It appears that although
80% of renal cortical tumors are malignant, not all malignant
tumors undergo substantial active growth. Without tumor
growth, the risk of metastasis may be limited as well. Thus,
treatment strategy may differ according to the patient’s age,
general medical condition, and renal function status, as well
as the aggressiveness of the detected renal tumor. Since differ-
ent subtypes of renal tumors are associated with different clin-
ical implications, it is clinically important to differentiate these
lesions preoperatively (16,17).
The results of previous studies reported that certain imag-
ing features may be associated with speciﬁc subtypes of renal
cortical tumor. The degree of enhancement was the most valu-
able parameter for differentiation of RCC subtypes, as clear
cell RCCs enhance to a greater degree than other subtypes
of malignant lesions, especially papillary RCCs (5–7,9,11).
In addition, Herts et al. (5) previously found that papillary
RCCs are typically homogeneous and hypovascular on CT
and angiography. They also found that high attenuation in
tumors on CT correlates with clear cell carcinomas. Most of
these studies included only malignant lesions or, in some cases,
subgroups of malignant lesions in their analyses.
In our study we included solid renal masses of different eti-
ologies: both malignant and benign tumors, while our patient
cohort was relatively small (total of 61 renal masses and 39
masses of RCC).
In our study, there was one case of papillary subtype of
RCC which showed minimal enhancement in the CMP (HU
55.5) and homogenous faint enhancement in the NP (HU
83.1), compared to the enhancement pattern of RCC clear cell
subtype which showed intense enhancement in the early CMP
(HU 144.7 and 129.7) and rapid wash out of contrast in the
following NP (HU 79.8 and 88.4) respectively.
In this study we measured the HU of RCC lesions in differ-
ent phases of contrast injection. Since renal tumors are often
heterogeneous, we decided to measure areas of greatest
enhancement in the lesion rather than in the entire tumor. This
minimizes volume averaging effects from areas of cystic or
necrotic changes and truly reﬂects the vascularity of the tumor.
Because of the small size and heterogeneous nature of many
renal lesions, the selection of areas of greatest degree of
Fig. 5 A 19 year old female patient presented with left loin pain. US revealed left renal lower pole soft tissue mass. MDCT: Well deﬁned
large left middle and lower zonal soft tissue mass showing heterogeneous texture and measuring >7 cm in diameter. It shows intense
enhancement in the CMP and rapid wash out in the following NP (HU is 148.4 in MP, 94.4 in NP and 88.7 in EP). No evidence of
extension to perirenal fat or adrenals. Patent renal vein and IVC. No regional lymphadenopathy. No distant metastasis. CTA:
Hypertrophied main renal artery and supplying segmental branches with early venous ﬁlling of the draining veins (arrows). CTU: Lower
pole nephrogram defect (curved arrows) with compressed lower calyceal group, yet with no evidence of invasion. RCC.
222 M.H. Wahba et al.enhancement was based on visual assessment and was there-
fore somewhat subjective.
Despite our small number of patient population we were
able to predict certain particular patterns of enhancement in
RCC and TCC cases. 39 RCC masses (regardless their patho-
logical subtypes) showed intense enhancement in the CMP,
rapid decrease of enhancement in the following NP denoting
rapid wash out of contrast and ﬁnal decrease of HU in theEP. A signiﬁcant difference was detected between HU in
CMP and EP in cases of RCC (P value = 0.0002) and differ-
ence between HU in NP and EP in cases of RCC (P
value < 0.00001).
3 TCC lesions showed faint enhancement in the CMP, fur-
ther increase of enhancement in the following NP and ﬁnal
decrease of HU in the EP. A signiﬁcant difference was detected
between HU in NP and EP in cases of TCC (P value = 0.03).
Fig. 6 MDCT: Well deﬁned left renal middle zonal hypodense cortical lesion (arrows) measuring (>4 cm in diameter). It shows small
area of contact with the outer renal cortical surface. The mass shows evidence of enhancement throughout the phases (HU is 55.5 in MP,
83.1 in NP and 58.7 in EP). No adrenal masses. Patent renal vein and IVC. No regional lymphadenopathy. No distant metastasis. CTU:
No abnormality detected. Diagnosis: Renal Cell Carcinoma (Papillary) T1b N0 M0.
Multiphasic MDCT in diagnosis and staging of solid neoplastic renal masses 223Our study results showed that the presence of neovascular-
ity was mildly associated with a more aggressive tumor which
was rather an expected ﬁnding.
A limitation of our study was that the percentage of malig-
nant lesions (88.5%) may have been slightly higher than that in
the general population, since our institution is a tertiary refer-
ral center. However, even in the general population the inci-
dence of malignant renal lesions is much higher than that of
benign lesions.
In conclusion Multiphase CT has a major role in the diag-
nosis, characterization and staging of solid renal neoplastic
masses. It also provides valuable data about the extent and
spread of the mass, and fulﬁlls information about vascular
supply, venous thrombosis, excretory function and state of
the pelvicalyceal system whether invaded, compressed or
obstructed.Conﬂict of interest
We have no conﬂict of interest to declare.
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